These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26074803)

  • 1. No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol.
    Bolstad I; Andreassen OA; Groote IR; Haatveit B; Server A; Jensen J
    Front Hum Neurosci; 2015; 9():296. PubMed ID: 26074803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of haloperidol and aripiprazole on the human mesolimbic motivational system: A pharmacological fMRI study.
    Bolstad I; Andreassen OA; Groote I; Server A; Sjaastad I; Kapur S; Jensen J
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2252-61. PubMed ID: 26476705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aripiprazole and haloperidol on neural activation during the n-back in healthy individuals: A functional MRI study.
    Goozee R; Reinders AATS; Handley R; Marques T; Taylor H; O'Daly O; McQueen G; Hubbard K; Mondelli V; Pariante C; Dazzan P
    Schizophr Res; 2016 Jun; 173(3):174-181. PubMed ID: 25778615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Effects of an Acute Dose of Antipsychotic Medication on Motivation-mediated BOLD Activity Using fMRI and a Perceptual Decision-making Task.
    Delfin C; Reckless GE; Bolstad I; Groote I; Andreassen OA; Jensen J
    Neuroscience; 2020 Aug; 440():146-159. PubMed ID: 32473275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study.
    Goozee R; O'Daly O; Handley R; Reis Marques T; Taylor H; McQueen G; Hubbard K; Pariante C; Mondelli V; Reinders AA; Dazzan P
    Hum Brain Mapp; 2017 Apr; 38(4):1833-1845. PubMed ID: 28009070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
    Schlagenhauf F; Dinges M; Beck A; Wüstenberg T; Friedel E; Dembler T; Sarkar R; Wrase J; Gallinat J; Juckel G; Heinz A
    Schizophr Res; 2010 May; 118(1-3):189-200. PubMed ID: 20189356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
    Oshibuchi H; Inada K; Sugawara H; Ishigooka J
    Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    Leite JV; Guimarães FS; Moreira FA
    Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice.
    Fejgin K; Safonov S; Pålsson E; Wass C; Engel JA; Svensson L; Klamer D
    Psychopharmacology (Berl); 2007 Apr; 191(2):377-85. PubMed ID: 17235612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.
    Pan B; Huang XF; Deng C
    Int J Mol Sci; 2016 Mar; 17(4):459. PubMed ID: 27043526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of presynaptic 5-HT
    Mombereau C; Arnt J; Mørk A
    Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling.
    Brust TF; Hayes MP; Roman DL; Watts VJ
    Biochem Pharmacol; 2015 Jan; 93(1):85-91. PubMed ID: 25449598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-dependent effects of the D
    Sonnenschein SF; Gill KM; Grace AA
    Neuropsychopharmacology; 2019 Feb; 44(3):572-580. PubMed ID: 30267014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action.
    Tomasetti C; Dell'Aversano C; Iasevoli F; de Bartolomeis A
    Neuroscience; 2007 Nov; 150(1):144-58. PubMed ID: 17916411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties.
    Holthoewer D; Kirschbaum KM; Frisch J; Hiemke C; Schmitt U
    Pharmacopsychiatry; 2013 Jul; 46(5):175-80. PubMed ID: 23737243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.